Articles in section Research & Development
<< Opinion & Analysis | 447 articles | Royalties >> |
<< Previous | Pages 1 ..6 7 8 9 10 11 .. 45 | Next >> |
-
AstraZeneca Signs US$1.2 B RNA Modification Partnership with Accent Therapeutics
-
Gilead Continues Oncology Spree with US$2.2 B Arcus Deal
-
BMS Partners with Repare on Synthetic Lethal Target Discovery for US$65 M Upfront
-
Fate Therapeutics Partners with Janssen for iPSC-derived Immunotherapies
-
Dyno Therapeutics Launches with US$2 B Deals with Novartis and Sarepta
-
Vertex Signs US$1.6 B Gene Therapy Vector Partnership with Affinia
-
Gilead and Second Genome Sign US$1.5 B Microbiome-based Drug Discovery Deal
-
Atomwise Signs US$1 B Drug Discovery Deal with Bridge Biotherapeutics
-
Bicycle Signs US$1.7 B Immuno-oncology Collaboration with Genentech
-
Biogen Signs Preclinical Gene Editing Deal with Sangamo